SCHEMBL26665282

SCHEMBL26665282

CP(C)(=O)c1ccc(Nc2ccc(C(F)(F)F)cc2)c(Br)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.43
▸ AKR1C2 P52895 1/20 0.43
▸ MAPK1 P28482 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ XBP1 P17861 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ TEAD1 P28347 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ YAP1 P46937 1/20 0.38
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ DHODH Q02127 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26602811 0.86 CA12 (0.43) AKR1C3AKR1C2MAPK1MAPTXBP1
SCHEMBL26665556 0.81 AKR1C3 (0.40) AKR1C3AKR1C2DHODH
SCHEMBL26665331 0.75 LIPE (0.41) AKR1C3AKR1C2MAPK1MAPTNPSR1
SCHEMBL26665296 0.75 MAPT (0.43) AKR1C3AKR1C2MAPK1MAPTXBP1
SCHEMBL29074750 0.75 ALDH1A1 (0.50) AKR1C3AKR1C2MAPK1MAPTXBP1
SCHEMBL20779892 0.74 TEAD1 (0.62) AKR1C3AKR1C2MAPK1MAPTTEAD1
SCHEMBL26603003 0.74 TEAD1 (0.65) AKR1C3AKR1C2MAPK1TEAD1SMN1; SMN2
SCHEMBL25431454 0.73 TP53 (0.46) AKR1C3MAPTMEN1ALDH1A1KMT2A
SCHEMBL21053182 0.73 NOTUM (0.58) AKR1C3AKR1C2MAPTXBP1NPSR1
SCHEMBL25042639 0.71 SMN1; SMN2 (0.51) AKR1C3MAPTXBP1NPSR1TEAD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023204822-A1 PHENYL PHOSPHINE OXIDE COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-10-26 — — WO disclosed
Send feedback